Hospitals stop gender care for minors amid federal pressure
In recent months, there has been a significant shift in the provision of gender-affirming care for young transgender individuals across the United States. At least nine hospitals or health systems have made the decision to halt the administration of gender-affirming hormones and puberty blockers to minors. This decision comes in response to federal rules proposed in December that threaten to withhold Medicare and Medicaid funding from clinics that continue to offer pediatric care for transgender individuals.
A closer look at news reports reveals that over 40 hospitals nationwide have either paused or completely discontinued some form of gender-affirming care for young people since President Trump issued an executive order targeting such treatments early in his second term. The pressure from federal authorities, including referrals for investigation by the Department of Health and Human Service’s Office of Inspector General, has prompted many healthcare facilities to reevaluate their services.
Mike Stuart, HHS general counsel, has been vocal about the administration’s stance on transgender healthcare, stating that they will continue to investigate and take action against hospitals that provide gender-affirming care to minors. Despite the fact that the proposed CMS rules are not yet finalized and the executive order is facing legal challenges, many hospitals have chosen to preemptively comply with the restrictions, leading to a reduction in services for transgender youth.
Numerous hospitals that have historically offered estrogen, testosterone, and puberty blockers to trans adolescents have announced their decision to stop providing these medications. This includes prominent healthcare systems like Rady Children’s Health in California and Children’s Minnesota in the Midwest. While some facilities have only ceased offering care to new patients, others have suspended services for all minors or individuals under the age of 19.
The uncertainty surrounding the future of transgender healthcare in light of the proposed CMS rules has created a challenging environment for hospitals and medical providers. The risk of losing Medicare and Medicaid funding has led many institutions to reconsider their approach to gender-affirming care. Legal experts warn that the broader implications of these actions could extend to other politicized health services in the future.
For now, young transgender patients are facing limited access to essential medical treatments, with many healthcare providers choosing to discontinue these services in response to federal pressure. This shift not only impacts the availability of care but also hinders the gathering of evidence and the improvement of patient outcomes in the field of transgender healthcare. As the debate continues, it remains to be seen how these changes will affect the well-being of transgender individuals seeking medical support.
